First Horizon Advisors’s US Physical Therapy USPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $76.9K | Sell |
983
-946
| -49% | -$69.7K | ﹤0.01% | 804 |
|
|
2025
Q1 | $140K | Buy |
1,929
+500
| +35% | +$42K | ﹤0.01% | 589 |
|
|
2024
Q4 | $127K | Sell |
1,429
-57
| -4% | -$5.08K | ﹤0.01% | 630 |
|
|
2024
Q3 | $126K | Buy |
1,486
+298
| +25% | +$26.4K | ﹤0.01% | 652 |
|
|
2024
Q2 | $110K | Buy |
1,188
+186
| +19% | +$18.8K | ﹤0.01% | 664 |
|
|
2024
Q1 | $113K | Hold |
1,002
| – | – | ﹤0.01% | 656 |
|
|
2023
Q4 | $93.4K | Buy |
1,002
+23
| +2% | +$2.02K | ﹤0.01% | 686 |
|
|
2023
Q3 | $89.8K | Buy |
979
+22
| +2% | +$2.36K | ﹤0.01% | 649 |
|
|
2023
Q2 | $116K | Buy |
957
+93
| +11% | +$10K | ﹤0.01% | 603 |
|
|
2023
Q1 | $84.6K | Buy |
864
+36
| +4% | +$3.44K | ﹤0.01% | 700 |
|
|
2022
Q4 | $67.1K | Buy |
828
+68
| +9% | +$5.7K | ﹤0.01% | 735 |
|
|
2022
Q3 | $57K | Sell |
760
-785
| -51% | -$75.5K | ﹤0.01% | 802 |
|
|
2022
Q2 | $168K | Buy |
1,545
+1,479
| +2,241% | +$157K | 0.01% | 502 |
|
|
2022
Q1 | $7K | Sell |
66
-258
| -80% | -$24.6K | ﹤0.01% | 1216 |
|
|
2021
Q4 | $31K | Buy |
324
+1
| +0.3% | +$100 | ﹤0.01% | 1123 |
|
|
2021
Q3 | $35K | Buy |
323
+1
| +0.3% | +$114 | ﹤0.01% | 1053 |
|
|
2021
Q2 | $37K | Buy |
322
+9
| +3% | +$1.03K | ﹤0.01% | 896 |
|
|
2021
Q1 | $32K | Hold |
313
| – | – | ﹤0.01% | 908 |
|
|
2020
Q4 | $37K | Hold |
313
| – | – | ﹤0.01% | 696 |
|
|
2020
Q3 | $27K | Hold |
313
| – | – | ﹤0.01% | 728 |
|
|
2020
Q2 | $25K | Buy |
313
+27
| +9% | +$1.97K | ﹤0.01% | 724 |
|
|
2020
Q1 | $19K | Hold |
286
| – | – | ﹤0.01% | 753 |
|
|
2019
Q4 | $32K | Hold |
286
| – | – | ﹤0.01% | 702 |
|
|
2019
Q3 | $37K | Buy |
286
+51
| +22% | +$6.64K | ﹤0.01% | 638 |
|
|
2019
Q2 | $28K | Buy |
235
+1
| +0.4% | +$115 | ﹤0.01% | 754 |
|
|
2019
Q1 | $24K | Hold |
234
| – | – | ﹤0.01% | 772 |
|
|
2018
Q4 | $23K | Buy |
234
+9
| +4% | +$999 | ﹤0.01% | 746 |
|
|
2018
Q3 | $26K | Hold |
225
| – | – | ﹤0.01% | 791 |
|
|
2018
Q2 | $21K | Buy |
225
+121
| +116% | +$11.2K | ﹤0.01% | 892 |
|
|
2018
Q1 | $9K | Buy |
104
+1
| +1% | +$78 | ﹤0.01% | 1043 |
|
|
2017
Q4 | $7K | Buy |
103
+35
| +51% | +$2.39K | ﹤0.01% | 1140 |
|
|
2017
Q3 | $4K | Hold |
68
| – | – | ﹤0.01% | 1225 |
|
|
2017
Q2 | $4K | Sell |
68
-76
| -53% | -$4.86K | ﹤0.01% | 1214 |
|
|
2017
Q1 | $9K | Buy |
+144
| New | +$10.2K | ﹤0.01% | 1051 |
|
|
2016
Q1 | – | Sell |
-141
| Closed | -$8K | – | 1408 |
|
|
2015
Q4 | $8K | Hold |
141
| – | – | ﹤0.01% | 968 |
|
|
2015
Q3 | $6K | Hold |
141
| – | – | ﹤0.01% | 1134 |
|
|
2015
Q2 | $8K | Hold |
141
| – | – | ﹤0.01% | 1098 |
|
|
2015
Q1 | $7K | Hold |
141
| – | – | ﹤0.01% | 1153 |
|
|
2014
Q4 | $6K | Buy |
+141
| New | +$5.55K | ﹤0.01% | 1192 |
|
|
2014
Q1 | – | Sell |
-1
| Closed | – | – | 1491 |
|
|
2013
Q4 | $0 | Buy |
+1
| New | +$33 | ﹤0.01% | 1407 |
|
Other funds holding USPH
CCM
SAM
BTW
GKIM
First Horizon Advisors's USPH Position: Q2 2025 in Review
First Horizon Advisors reduced its US Physical Therapy (USPH) stake by 49% in Q2 2025, selling an estimated $69.7K and leaving 983 shares worth $76.9K. The position accounts for ﹤0.01% of the portfolio, ranked #804.
First Horizon Advisors first reported a position in USPH in Q4 2013 and has held it in 40 quarters since. The position peaked at $168K in Q2 2022. 240 funds tracked by Wall St. Rank hold USPH as of Q2 2025.
- First Horizon Advisors held 983 shares of US Physical Therapy worth $76.9K as of Q2 2025.
- First Horizon Advisors sold 946 US Physical Therapy shares in Q2 2025, an estimated $69.7K.
- US Physical Therapy made up ﹤0.01% of First Horizon Advisors's portfolio in Q2 2025, its #804 holding.
- First Horizon Advisors first reported a position in US Physical Therapy in Q4 2013 and has held it in 40 quarters since.
- First Horizon Advisors's US Physical Therapy position peaked at $168K in Q2 2022.
- 240 funds tracked by Wall St. Rank held US Physical Therapy as of Q2 2025.
Based on First Horizon Advisors's 13F filing for Q2 2025, filed 6 Aug 2025.